 |
|
Optimizing Management of Rash Associated With EGFR Inhibitors: A Workshop for Oncology Nurses
This presentation will review the management of rash experienced by patients receiving the novel class of agents that target EGFR. Although generally well tolerated, EGFR inhibitors are associated with dermatologic reactions in most patients—yet no evidence-based management guidelines have been established. In this regional CE program, oncology nurse experts will provide thorough answers to oncology nurses’ most pressing questions related to the administration of EGFR inhibitors in clinical practice. The pathophysiology of cellular signaling pathways involved in EGFR inhibition and mechanisms of action of EGFR inhibitors will be presented in 3-D video animation. Thought leaders will review the clinical application and ongoing investigations of agents, and provide a comprehensive review of rash assessment and management. Case presentations will be used to support key learning objectives. At the commencement of each program, nurses will be encouraged to participate in a survey regarding experiences with rash assessment tools and management. The results of the survey will be collated, and will specifically evaluate variations in assessment and management based on demographics and practice setting. Results will highlight knowledge gaps and provide direction for subsequent CE programs.
|
|
 |
|
A Call-to-Action Workshop: Oncology Nurse Management of Hypersensitivity Reactions
Numerous cancer therapies are associated with HSRs. These infusion-related reactions can range in severity from mild flushing and itching, to anaphylaxis, and in rare cases, death. The accurate identification of the signs and symptoms of HSRs can directly affect treatment decisions. If patients at high risk for experiencing a second reaction can be safely rechallenged, discontinuation of an effective agent may be avoided. It is imperative that oncology nurses are aware of the potential for HSRs when administering therapeutic agents and have protocols in place to prevent and manage these reactions in order to minimize their effects on future treatment.
|
